Biochemical characteristics among Mycobacterium bovis BCG substrains

被引:14
|
作者
Hayashi, Daisuke
Takii, Takemasa [1 ]
Mukai, Tetsu [2 ]
Makino, Masahiko [2 ]
Yasuda, Emi
Horita, Yasuhiro
Yamamoto, Ryuji
Fujiwara, Akiko
Kanai, Keita
Kondo, Maki
Kawarazaki, Aya
Yano, Ikuya [3 ]
Yamamoto, Saburo [3 ]
Onozaki, Kikuo
机构
[1] Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan
[2] Natl Inst Infect Dis, Dept Mycobacteriol, Leprosy Res Ctr, Tokyo, Japan
[3] Japan BCG Lab, Tokyo, Japan
关键词
BCG; substrain; vaccine; biochemical characteristics; tuberculosis; NITRATE REDUCTASE NARGHJI; IN-VITRO; TUBERCULOSIS; RESISTANCE; VIRULENCE;
D O I
10.1111/j.1574-6968.2010.01947.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In order to evaluate the biochemical characteristics of 14 substrains of Mycobacterium bovis bacillus Calmette Guerin (BCG) - Russia, Moreau, Japan, Sweden, Birkhaug, Danish, Glaxo, Mexico, Tice, Connaught, Montreal, Phipps, Australia and Pasteur - we performed eight different biochemical tests, including those for nitrate reduction, catalase, niacin accumulation, urease, Tween 80 hydrolysis, pyrazinamidase, p-amino salicylate degradation and resistance to thiophene 2-carboxylic acid hydrazide. Catalase activities of the substrains were all low. Data for nitrate reduction, niacin accumulation, Tween 80 hydrolysis, susceptibility to hydrogen peroxide and nitrate, and optimal pH for growth were all variable among these substrains. These findings suggest that the heterogeneities of biochemical characteristics are relevant to the differences in resistance of BCG substrains to environmental stress. The study also contributes to the re-evaluation of BCG substrains for use as vaccines.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [31] Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
    Dellagostin, Odir Antonio
    Borsuk, Sibele
    Oliveira, Thais Larre
    Seixas, Fabiana Kommling
    VACCINES, 2022, 10 (05)
  • [32] Mycobacterium bovis BCG in metastatic melanoma therapy
    Martha Lucia Ruiz Benitez
    Camila Bonnemann Bender
    Thaís Larré Oliveira
    Kyle M. Schachtschneider
    Tiago Collares
    Fabiana Kömmling Seixas
    Applied Microbiology and Biotechnology, 2019, 103 : 7903 - 7916
  • [33] Immunosorbents for the preparation of Mycobacterium bovis BCG antigen
    Krejcikova, S
    Benes, MJ
    Wisingerova, E
    Turkova, J
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1996, 61 (12) : 1823 - 1830
  • [34] Mycobacterium bovis BCG in metastatic melanoma therapy
    Ruiz Benitez, Martha Lucia
    Bender, Camila Bonnemann
    Oliveira, Thais Larre
    Schachtschneider, Kyle M.
    Collares, Tiago
    Seixas, Fabiana Koemmling
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (19) : 7903 - 7916
  • [35] DEOXYRIBONUCLEIC-ACID RELATEDNESS AMONG SELECTED STRAINS OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-BOVIS, MYCOBACTERIUM-BOVIS BCG, MYCOBACTERIUM-MICROTI, AND MYCOBACTERIUM-AFRICANUM
    IMAEDA, T
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1985, 35 (02): : 147 - 150
  • [36] Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid:: Differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis
    Kang, Sung-Koo
    Lee, Jong-Ho
    Lee, Young-Choon
    Kim, Cheorl-Ho
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (05): : 724 - 729
  • [37] Functional expression of the Flp recombinase in Mycobacterium bovis BCG
    Song, Houhui
    Niederweis, Michael
    GENE, 2007, 399 (02) : 112 - 119
  • [39] FATTY-ACIDS OF MYCOBACTERIUM-BOVIS BCG
    OLSON, WP
    GROVES, MJ
    KLEGERMAN, ME
    MICROBIOS, 1989, 57 (232-33) : 151 - 155